Admin-Core

管理核心

基本信息

项目摘要

ABSTRACT The Administrative Core will continue to manage the Center for Translational Therapeutics (CTT) by attending to all fiscal, organizational, programmatic, career-development, communication, mentoring, and evaluation aspects of the Center. The Specific Aims of this Core are: 1) To continue managing all the organizational, fiscal, scientific oversight, communication, reporting and evaluation aspects of the CTT. This will include interacting with other institutional components for the fiscal management of the CTT, the recruitment of new faculty into the Center, and the replacement of target faculty who have attained independence; organizing and supporting External Advisory Committee (EAC) visits; collecting, organizing and re-distributing as appropriate all the information needed for reporting and evaluation of the CTT by the EAC and producing the Annual Progress Report for NIGMS; and maintaining a web presence to connect the CTT with the participating institutions and with other IDeA programs/centers in and outside the state, the NIGMS, and the scientific community. 2) To continue fostering the career development of junior investigators, promote their progress toward independent funding, and support their continued participation in the CTT, once they attain independence. This will include organizing and managing all CTT meetings, seminars, symposia and other similar activities; mediating communication for mentoring activities and for the review of drafts of grant proposals and manuscripts; and ultimately creating a research environment conducive to the development of young scientists and to accelerating discoveries with inherent applicability in the clinical setting. 3) To promote the formation of teams of investigators and continue promoting the generation of new ideas within the CTT and connecting the CTT with surrounding programs. The pilot project program will provide funding for targeted projects each year, aiming at promoting team science, and generating preliminary data leading to applications for multi-investigator and SBIR/STTR grant proposals, alongside the traditional individual R01 or equivalent. In addition to targeted funding for collaborative teams, the CTT will implement specific strategies to promote collaborations, including (but not limited to) targeted hires to complement existing strengths; tailored mentoring and training; structured opportunities for brainstorming and the generation of ideas; and support for the submission of team-based grant proposals. The Administrative Core will be managed by the PI/Center Director, with a half-time Scientific Coordinator and a full-time Program Manager; and by the Steering Committee composed of the PI, Scientific Coordinator and Core Leaders. An Internal Advisory Committee and a cadre of Mentors will assist the PI in the management of the program. In addition, an External Advisory Committee will provide external evaluation, and support the PI in the scientific development of the Center.
抽象的 行政核心将继续通过参加转化治疗中心(CTT) 所有财政,组织,程序化,职业发展,沟通,指导和评估 中心的各个方面。该核心的具体目的是: 1)继续管理所有组织,财政,科学监督,沟通,报告 和CTT的评估方面。这将包括与其他机构组件进行互动 CTT的财政管理,新教师招募中心以及更换目标 获得独立的教师;组织和支持外部咨询委员会(EAC)访问; 收集,组织和重新分发报告和评估所需的所有信息 EAC的CTT并生成了Nigms的年度进度报告;并维护网络 与参与机构以及其他想法计划/中心与参与机构连接起来的存在 在州外,黑人和科学界之外。 2)继续培养初级调查人员的职业发展,请促进他们的进步 一旦获得独立资金,并支持他们继续参与CTT 独立。这将包括组织和管理所有CTT会议,研讨会,研讨会和其他 类似的活动;调解沟通以指导活动和审查赠款的草案 建议和手稿;并最终创造了有利于发展的研究环境 年轻的科学家,并在临床环境中具有固有的适用性加速发现。 3)促进调查人员团队的组成,并继续促进新的新产生 CTT中的想法并将CTT与周围程序联系起来。试点项目计划将 每年为目标项目提供资金,旨在促进团队科学并产生 初步数据导致了多入侵者和SBIR/STTR授予建议的应用程序, 与传统的个人R01或同等学历一起。除了有针对性的合作资金 团队,CTT将实施特定策略来促进合作,包括(但不限于) 有针对性的员工补充现有的优势;量身定制的指导和培训;结构化的机会 集思广益和创造思想的产生;并支持提交基于团队的赠款建议。这 行政核心将由PI/Center主任管理,并由半场科学协调员和 专职计划经理;由PI,科学协调员和指导委员会组成 核心领导者。内部咨询委员会和导师干部将协助PI管理 该程序。此外,外部咨询委员会将提供外部评估,并支持PI 中心的科学发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IGOR B RONINSON其他文献

IGOR B RONINSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IGOR B RONINSON', 18)}}的其他基金

Synthetic Transcriptional Activators for Cancer Immunotherapy
用于癌症免疫治疗的合成转录激活剂
  • 批准号:
    10850109
  • 财政年份:
    2023
  • 资助金额:
    $ 91.04万
  • 项目类别:
Synthetic Transcriptional Activators for Cancer Immunotherapy
用于癌症免疫治疗的合成转录激活剂
  • 批准号:
    10868915
  • 财政年份:
    2023
  • 资助金额:
    $ 91.04万
  • 项目类别:
Center for Targeted Therapeutics
靶向治疗中心
  • 批准号:
    10372263
  • 财政年份:
    2014
  • 资助金额:
    $ 91.04万
  • 项目类别:
Center for Targeted Therapeutics
靶向治疗中心
  • 批准号:
    9978871
  • 财政年份:
    2014
  • 资助金额:
    $ 91.04万
  • 项目类别:
Center for Targeted Therapeutics
靶向治疗中心
  • 批准号:
    8885848
  • 财政年份:
    2014
  • 资助金额:
    $ 91.04万
  • 项目类别:
Center for Targeted Therapeutics
靶向治疗中心
  • 批准号:
    10221696
  • 财政年份:
    2014
  • 资助金额:
    $ 91.04万
  • 项目类别:
Admin-Core
管理核心
  • 批准号:
    10403529
  • 财政年份:
    2014
  • 资助金额:
    $ 91.04万
  • 项目类别:
Center for Targeted Therapeutics
靶向治疗中心
  • 批准号:
    9794379
  • 财政年份:
    2014
  • 资助金额:
    $ 91.04万
  • 项目类别:
Admin-Core
管理核心
  • 批准号:
    10221715
  • 财政年份:
    2014
  • 资助金额:
    $ 91.04万
  • 项目类别:
METABOLIC ANALYSIS INSTRUMENTATION TO ENHANCE TARGETED THERAPEUTICS STUDIES
代谢分析仪器可增强靶向治疗研究
  • 批准号:
    10400414
  • 财政年份:
    2014
  • 资助金额:
    $ 91.04万
  • 项目类别:

相似海外基金

Access for All in ALS (ALL ALS) West Clinical Coordinating Center
ALS 所有人 (ALL ALS) 西部临床协调中心
  • 批准号:
    10878596
  • 财政年份:
    2023
  • 资助金额:
    $ 91.04万
  • 项目类别:
Colorado Clinical and Translational Sciences Institute (CCTSI)
科罗拉多临床与转化科学研究所 (CCTSI)
  • 批准号:
    10764161
  • 财政年份:
    2023
  • 资助金额:
    $ 91.04万
  • 项目类别:
Impact of Congenital Hyperinsulinism on Trajectories of Neurocognitive Function Across School Age
先天性高胰岛素血症对整个学龄期神经认知功能轨迹的影响
  • 批准号:
    10723317
  • 财政年份:
    2023
  • 资助金额:
    $ 91.04万
  • 项目类别:
Mechanisms of lipid droplet trafficking in hepatocellular carcinoma
肝细胞癌中脂滴运输的机制
  • 批准号:
    10644812
  • 财政年份:
    2023
  • 资助金额:
    $ 91.04万
  • 项目类别:
Genomic Regulation and Translational Potential of a Novel Smooth Muscle Cell-Derived Cell Type in Atherosclerosis
动脉粥样硬化中新型平滑肌细胞衍生细胞类型的基因组调控和转化潜力
  • 批准号:
    10553197
  • 财政年份:
    2022
  • 资助金额:
    $ 91.04万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了